Population Pharmacokinetic and Pharmacodynamic Analysis To Evaluate a Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in People Living with HIV-1

Doravirine is a non-nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus type 1 (HIV-1) infection. A population pharmacokinetic (PK) model for treatment-naive participants in doravirine clinical studies was updated with data from switch participants in the DRIVE-S...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaddady, Pavan, Kandala, Bhargava, Yee, Ka Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577165/
https://www.ncbi.nlm.nih.gov/pubmed/32868326
http://dx.doi.org/10.1128/AAC.00590-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577165/
https://www.ncbi.nlm.nih.gov/pubmed/32868326
http://dx.doi.org/10.1128/AAC.00590-20

Ejemplares similares